The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Marketwire

ProMetic to Present at Biotech Showcase 2011

Wednesday, January 05, 2011

ProMetic to Present at Biotech Showcase 201106:00 EST Wednesday, January 05, 2011MONTREAL, QUEBEC--(Marketwire - Jan. 5, 2011) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announced that Mr. Pierre Laurin, President and Chief Executive Officer, will be giving a corporate presentation at the upcoming Biotech Showcase 2011 conference. Mr. Laurin will be speaking on Wednesday, January 12, 2011, at 10:15 (PST) in the Stockton Room of the Parc 55 Wyndham San Francisco – Union Square, San Francisco, California, USA. A live audio webcast of the presentation will be available through ProMetic's website at http://www.prometic.com/en/news-events/events.php.About Biotech Showcase 2011Biotech Showcase 2011 (http://www.ebdgroup.com/bts/index.htm), which is focused on biotechnology, provides private and public presenting companies an opportunity to present to an audience of investors and biopharmaceutical business development executives.About ProMetic Life Sciences Inc.ProMetic Life Sciences Inc. ("ProMetic") (www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the US, Europe, Asia and in the Middle-East.FOR FURTHER INFORMATION PLEASE CONTACT: Pierre LaurinProMetic Life Sciences Inc.President and CEO514-341-2115p.laurin@prometic.comORAnne LeducProMetic Life Sciences Inc.Manager, Investor Relations & Communications514-341-2115a.leduc@prometic.com